A Study of TRK-950 When Used in Combination With Ramucirumab and Paclitaxel in Patients With Gastric Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

Gastric Adenocarcinoma · Gastric Cancer · Gastroesophageal Junction Adenocarcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • City of Hope, Duarte, California, United States

    Contact: Study coordinator (MD) · 877-467-3411
  • City of Hope at Orange County Lennar Foundation Cancer Center, Irvine, California, United States

    Contact: Study coordinator (MD) · 877-467-3411
  • University of California, Los Angeles, Santa Monica, California, United States

    Study coordinator · 888-662-8252
  • Texas Oncology Arlington North, Arlington, Texas, United States

  • Texas Oncology Bedford, Bedford, Texas, United States

  • Texas Oncology Dallas Methodist, Dallas, Texas, United States

  • Texas Oncology Dallas Medical City, Dallas, Texas, United States

  • Texas Oncology Dallas Presbyterian, Dallas, Texas, United States

  • Texas Oncology Methodist Charlton Cancer Center, Dallas, Texas, United States

  • Texas Oncology-Sammons Cancer Center, Dallas, Texas, United States

    Contact: Study coordinator (Clinical Research Coordinator II) · (214)370-1942
  • Texas Oncology Fort Worth Cancer Center, Fort Worth, Texas, United States

  • Texas Oncology Grapevine, Grapevine, Texas, United States

  • Texas Oncology Plano East, Plano, Texas, United States

  • Texas Oncology Plano West, Plano, Texas, United States

  • Kanagawa Prefectural Hospital Organization Kanagawa Cancer Center, Yokohama, Kanagawa, Japan

    Contact: Study coordinator (Principal Investigator)
  • Saitama Prefectural Hospital Organization Saitama Cancer Center, Shinden, Saitama, Japan

    Contact: Study coordinator (Principal Investigator)
  • Shizuoka Cancer Center, Nagaizumi-cho, Shizuoka, Japan

    Contact: Study coordinator (Principal Investigator)
  • National Cancer Center Hospital, Chūōku, Japan

    Contact: Study coordinator (Principal Investigator)
  • Osaka International Cancer Institute, Chūōku, Japan

    Contact: Study coordinator (Prinicipal Investigator)
  • National Cancer Center Hospital East, Kashiwa, Japan

    Contact: Study coordinator (Principal Investigator)
  • The Cancer Institute Hospital of JFCR, Kōtoku, Japan

  • Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, South Korea

    Contact: Study coordinator (Principal Investigator)
  • Chonnam National University Hwasun Hospital, Hwasun, Jeollanam-do, South Korea

    Contact: Study coordinator (Principal Investigator)
  • Kyungpook National University Chilgok Hospital, Daegu, South Korea

    Contact: Study coordinator (Principal Investigator)
  • Severance Hospital, Seoul, South Korea

    Contact: Study coordinator (Principal Investigator)
  • ASAN Medical Center, Seoul, South Korea

    Contact: Study coordinator (Principal Investigator)
  • Samsung Medical Center, Seoul, South Korea

    Contact: Study coordinator (Principal Investigator)